Burkitt's lymphoma in 63 Turkish children diagnosed over a 10 year period

Pediatric Hematology and Oncology

Volumn 13, Issue 2, 1996, Pages 123-134

  Ertem, Ulya ^a,c   Duru, Feride ^a   Pamir, Ali ^a   Taçyildiz, Nurdan ^a   Daǧdemir, Ayhan ^a   Akçayöz, Ayşegül ^a   Uluoǧlu, Ömer ^b   Teziç, Tahsin ^a  

^a DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

^c Asagi Ayranci Yesilyurt Sok No:25/14   (Turkey)

Author keywords

Burkitt's lymphoma; childhood; Turkey

Indexed keywords

VIRUS CAPSID ANTIGEN;

ADOLESCENT; AGE DISTRIBUTION; ANTIBODY TITER; ARTICLE; BURKITT LYMPHOMA; CHILD; CHILDHOOD CANCER; CLINICAL FEATURE; EPSTEIN BARR VIRUS; FEMALE; GROWTH RETARDATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PLEURA EFFUSION; SOLID TUMOR; TURKEY (REPUBLIC);

EID: 0029940681     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.3109/08880019609030802     Document Type: Article

References (25)

1. Magrath I, Jain V and Bhatia K. Epstein-Barr virus and Burkitt's lymphoma. Semin Cancer Biol. 1992;3:285-295.
2. Bouffet E, Frappaz R, Pinkerton R, et al. Burkitt's lymphoma: A model for clinical oncology. Eur J Cancer. 1991;27:504-509.
3. Hutchison RE, Murphy SB, Fairclough DL, et al. Diffuse small noncleaved cell lymphoma in children, Burkitt's versus non-Burkitt's types. Cancer. 1989;64:23-28.
4. Burke JS. The histopathologic classification of non-Hodgkin's lymphomas: Ambiguities in Working Formulation and two newly reported categories. Semin Oncol. 1990;17:3-10.
5. Johnston JM, Yu MT, and Carroll WL. c-myc hypermutation is ongoing in endemic, but not all Burkitt's lymphoma. Blood 1991;78:2419-2425.
6. Shiramizu B, Barriga F, Neequaye J, et al. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma. Relevance to geography and Epstein-Barr virus association. Blood. 1991; 77:1516-1526.
7. Shiramizu B, Magrath I. Localization of break points by polymerase chain reactions in Burkitt's lymphoma. Blood. 1990;75:1848-1852.
8. Berard C, O'Conor GT, Thomas LB, et al. Histopathological definition of Burkitt's tumor. Bull World Health Organ. 1969;40:601-607.
9. Magrath I. African Burkitt's lymphoma: History, biology, clinical features and treatment. Am J Pediatr Hematol Oncol. 1991;13:222-246.
10. Bramswig JH, Wegele M, Lengerke HJV, et al. The effect of the number of fractions of cranial irradiation on growth in children with acute lymphoblastic leukaemia. Acta Pediatr Scand. 1989; 78:296-230.
11. Tanner JM, Whitehouse RM, Takaishi M. Standards from birth to maturity for height, weight, and height velocity. Arch Dis Child. 1966;41:613-635.
12. Ziegler JH. Treatment of 54 American patients with Burkitt's lymphoma is similar to the African experience. N Engl J Med. 1977;297:75-80.
13. Al-Attar A, Al-Mondhiry H, Al-Bahrani Z, et al. Burkitt's lymphoma in Iraq; Clinical and pathologic study of 47 patients. Int J Cancer. 1979;23:14-17.
14. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patients. Br J Cancer. 1977;35:1-39.
15. Murphy SB, Bowman WP, Abromowitch M, et al. Results of treatment of advanced-stage Burkitt's lymphoma and B cell(Slg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol. 1986; 4:1732-1739.
16. Çavdar AO, Yavuz G, Babacan E, et al. Burkitt's lymphoma in Turkish children: Clinical, viral (EBV) and molecular studies. Leuk Lymphoma. 1994;14:323-330.
17. Kutluk T, Sanalioǧlu F, Göǧüş S, et al. Burkitt's lymphoma in Turkish children: A retrospective analysis of 104 cases. Turk J Cancer. 1993;23:81-88.
18. Magrath I. The pathogenesis of Burkitt's lymphoma. Adv Cancer Res. 1990;55:133-270.
19. Yih WY, Myers SL, Meshul CK, et al. African Burkitt's lymphoma: Case report and light and electron microscopic findings. Oral Surg Oral Med Oral Pathol. 1990;70:760-764.
20. DeThe G, Gaser A, Day NE, et al. Epidemiological evidence for a causal relationship between Epsten-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature. 1978;274: 756-761.
21. Durbin WA, Sullivan JL. Epstein-Barr virus infection. Pediatr Rev. 1994;15:63-68.
22. Katz BZ, Raab-Traub N, Miller G. Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative disease. J Infect Dis. 1989;160:589-598.
23. Çavdar AO, Gözdaşoǧlu S, Yavuz G, et al. Burkitt's lymphoma between African and American types in Turkish children: Clinical, viral (EBV) and molecular studies. Med Pediatr Oncol. 1993; 21:36-42.
24. Magrath I, Lee YJ, Anderson T, et al. Prognostic factors in Burkitt's lymphoma importance of total tumor burden. Cancer. 1980;45:1507-1515.
25. Schwenn R, Blattner R, Lynch E, et al. HiC-COM: A 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia. J Clin Oncol. 1991;9:133-138.